Thrombopoietic agents enhance bone healing in mice, rats, and pigs

Achieving bone union remains a significant clinical dilemma. The use of osteoinductive agents, specifically bone morphogenetic proteins (BMPs), has gained wide attention. However, multiple side effects, including increased incidence of cancer, have renewed interest in investigating alternatives that provide safer, yet effective bone regeneration. Here we demonstrate the robust bone healing capabilities of the main megakaryocyte (MK) growth factor, thrombopoietin (TPO), and second-generation TPO agents using multiple animal models, including mice, rats, and pigs. This bone healing activity is shown in two fracture models (critical-sized defect [CSD] and closed fracture) and with local or systemic administration. Our transcriptomic analyses, cellular studies, and protein arrays demonstrate that TPO enhances multiple cellular processes important to fracture healing, particularly angiogenesis, which is required for bone union. Finally, the therapeutic potential of thrombopoietic agents is high since they are used in the clinic for other indications (eg, thrombocytopenia) with established safety profiles and act upon a narrowly defined population of cells.

Authors

Institutions

Publication Details

Journal
Journal of Bone and Mineral Research
Published
2024-11-20
DOI
https://doi.org/10.1093/jbmr/zjae191
Citations
2
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thrombopoietic agents enhance bone healing in mice, rats, and pigs

K. Shively, Aamir Tucker, Aarti Gautam, Edward F. Srour et al.
2 citations
Journal of Bone and Mineral Research
Blood transfusion and management
0.45
article

Thrombopoietic agents enhance bone healing in mice, rats, and pigs

K. Shively, Aamir Tucker, Aarti Gautam, Edward F. Srour, Philip Stewart Low, Thomas B. Bemenderfer, Kelli J. Manikowski, Joydeep Ghosh, W. Christopher Shelley, Patrick L. Mulcrone, Jeffery J. Nielsen, Melissa A. Kacena, Krista L. Jackson, Andrew Engle, A. R. Wessel, Mervin C. Yöder, Marta Alvarez, Paul Childress, Alexander Brinker, Jonathan S. Harris, Jeffrey D. Rytlewski, Nabarun Chakraborty, Roman M. Natoli, K.S. Griffin, Jonathan W. Lowery, Ushashi C. Dadwal, Ying‐Hua Cheng, Todd O. McKinley, Jonathan H. Wilhite, Patrick D. Millikan, David C. Scofield, Rasha Hammamieh, Tien‐Min Gabriel Chu, Stewart A. Low, Jeffrey O. Anglen, Stacy Ann Miller, Monique Bethel
article en
2 citations

Abstract

Achieving bone union remains a significant clinical dilemma. The use of osteoinductive agents, specifically bone morphogenetic proteins (BMPs), has gained wide attention. However, multiple side effects, including increased incidence of cancer, have renewed interest in investigating alternatives that provide safer, yet effective bone regeneration. Here we demonstrate the robust bone healing capabilities of the main megakaryocyte (MK) growth factor, thrombopoietin (TPO), and second-generation TPO agents using multiple animal models, including mice, rats, and pigs. This bone healing activity is shown in two fracture models (critical-sized defect [CSD] and closed fracture) and with local or systemic administration. Our transcriptomic analyses, cellular studies, and protein arrays demonstrate that TPO enhances multiple cellular processes important to fracture healing, particularly angiogenesis, which is required for bone union. Finally, the therapeutic potential of thrombopoietic agents is high since they are used in the clinic for other indications (eg, thrombocytopenia) with established safety profiles and act upon a narrowly defined population of cells.

Journal of Bone and Mineral ResearchVol. 40(1)
Purdue University West Lafayette (US), Richard L. Roudebush VA Medical Center (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Marian University - Indiana (US), Walter Reed Army Institute of Research (US)
U.S. Department of Defense, Indiana Clinical and Translational Sciences Institute, Indiana University Health, Orthopaedic Trauma Association, National Institutes of Health, Medical Research and Materiel Command
Good health and well-being
Openalex Percentile: Top 42%
Blood transfusion and management
0.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.